Works matching IS 13419625 AND DT 2023 AND VI 28 AND IP 5

Results: 13
    1

    Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi‑institutional retrospective study.

    Published in:
    2023
    By:
    • Kato, Renpei;
    • Naito, Sei;
    • Numakura, Kazuyuki;
    • Hatakeyama, Shingo;
    • Koguchi, Tomoyuki;
    • Kojima, Takahiro;
    • Kawasaki, Yoshihide;
    • Kandori, Shuya;
    • Kawamura, Sadafumi;
    • Arai, Yoichi;
    • Ito, Akihiro;
    • Nishiyama, Hiroyuki;
    • Kojima, Yoshiyuki;
    • Ohyama, Chikara;
    • Habuchi, Tomonori;
    • Tsuchiya, Norihiko;
    • Obara, Wataru
    Publication type:
    Correction Notice
    2

    Lineage of drug discovery research on fluorinated pyrimidines: chronicle of the achievements accomplished by Professor Setsuro Fujii.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 5, p. 613, doi. 10.1007/s10147-023-02326-w
    By:
    • Maehara, Yoshihiko;
    • Oki, Eiji;
    • Ota, Mitsuhiko;
    • Harimoto, Norifumi;
    • Ando, Koji;
    • Nakanishi, Ryota;
    • Kawazoe, Tetsuro;
    • Fujimoto, Yoshiaki;
    • Nonaka, Kentaro;
    • Kitao, Hiroyuki;
    • Iimori, Makoto;
    • Makino, Kunio;
    • Takechi, Teiji;
    • Sagara, Takeshi;
    • Miyadera, Kazutaka;
    • Matsuoka, Kazuaki;
    • Tsukihara, Hiroshi;
    • Kataoka, Yuki;
    • Wakasa, Takeshi;
    • Ochiiwa, Hiroaki
    Publication type:
    Article
    3

    Plasma trough concentration of imatinib and its effect on therapeutic efficacy and adverse events in Japanese patients with GIST.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 5, p. 680, doi. 10.1007/s10147-023-02325-x
    By:
    • Teranishi, Ryugo;
    • Takahashi, Tsuyoshi;
    • Nishida, Toshirou;
    • Kurokawa, Yukinori;
    • Nakajima, Kiyokazu;
    • Koh, Masahiro;
    • Nishigaki, Takahiko;
    • Saito, Takuro;
    • Yamamoto, Kazuyoshi;
    • Yamashita, Kotaro;
    • Tanaka, Koji;
    • Makino, Tomoki;
    • Motoori, Masaaki;
    • Omori, Takeshi;
    • Hirota, Seiichi;
    • Hayashi, Yoshito;
    • Takehara, Tetsuo;
    • Eguchi, Hidetoshi;
    • Doki, Yuichiro
    Publication type:
    Article
    4
    5
    6
    7
    8

    Regulation of MEK inhibitor selumetinib sensitivity by AKT phosphorylation in the novel BRAF L525R mutant.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 5, p. 654, doi. 10.1007/s10147-023-02318-w
    By:
    • Nakai, Chikako;
    • Mimaki, Sachiyo;
    • Matsushima, Koutatsu;
    • Shinozaki, Eiji;
    • Yamazaki, Kentaro;
    • Muro, Kei;
    • Yamaguchi, Kensei;
    • Nishina, Tomohiro;
    • Yuki, Satoshi;
    • Shitara, Kohei;
    • Bando, Hideaki;
    • Suzuki, Yutaka;
    • Akagi, Kiwamu;
    • Nomura, Shogo;
    • Fujii, Satoshi;
    • Sugiyama, Masaya;
    • Nishida, Nao;
    • Mizokami, Masashi;
    • Koh, Yasuhiro;
    • Koshizaka, Takuya
    Publication type:
    Article
    9
    10
    11
    12
    13

    Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 5, p. 644, doi. 10.1007/s10147-023-02316-y
    By:
    • Ando, Masashi;
    • Honda, Kazunori;
    • Hosoda, Waki;
    • Matsubara, Yuki;
    • Kumanishi, Ryosuke;
    • Nakazawa, Taiko;
    • Ogata, Takatsugu;
    • Nakata, Akinobu;
    • Kodama, Hiroyuki;
    • Masuishi, Toshiki;
    • Narita, Yukiya;
    • Taniguchi, Hiroya;
    • Kadowaki, Shigenori;
    • Muro, Kei
    Publication type:
    Article